SPS
ROIV icon

Susquehanna Portfolio Strategies’s Roivant Sciences ROIV Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$957K Hold
27,035
– – 0.02% 563
2026
Q1 		$749K Hold
27,035
– – 0.01% 685
2025
Q4 		$587K Hold
27,035
– – 0.01% 748
2025
Q3 		$409K Buy
+27,035
New +$335K 0.01% 868

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Susquehanna Portfolio Strategies's ROIV Position: Q2 2026 in Review

Susquehanna Portfolio Strategies held its Roivant Sciences (ROIV) position steady in Q2 2026 at 27,035 shares worth $957K. The position accounts for 0.02% of the portfolio, ranked #563.

Susquehanna Portfolio Strategies first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Susquehanna Portfolio Strategies held 27,035 shares of Roivant Sciences worth $957K as of Q2 2026.
  • Susquehanna Portfolio Strategies left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #563 holding.
  • Susquehanna Portfolio Strategies first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.